Pharmafile Logo
Pharmafocus logo
Advanced Search

Omicron subvariant BA.2 likely to have same severity as ‘original’, says WHO

February 2, 2022
Research and Development

The BA.2 form of the Omicron coronavirus variant is unlikely to be any more severe than the original BA.1 form, …

News

FDA approval of six-annual-dose HIV treatment

February 2, 2022
Research and Development

ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for

News

First European filing submission for multiple myeloma bispecific antibody

February 2, 2022
Research and Development

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …

News

Technology on trial – the latest cogs in the clinical machine

February 1, 2022

From the integration of social media to everyday life, to the seeping of AI into our daily lives, the past …

Feature

Access denied: Is Brexit spelling bedlam for UK clinical trials?

February 1, 2022

Since Article 50 was triggered on the 29 March 2017, the UK’s pharmaceutical industry collectively held its breath, bracing itself …

Feature

Measles jab rate in England falls to ten percent below recommended rate

February 1, 2022
Medical Communications

Over one in 10 school entry-age children in England are at risk of measles due to not receiving their vaccine …

News

AI technology has the potential for breast cancer diagnosis

February 1, 2022
Manufacturing and Production

Academics at King’s College, London, and Guy’s and St Thomas’ NHS Foundation Trust, are using historical scans in a new …

News

WHO: COVID-19 hospital waste presents health threat

February 1, 2022
Manufacturing and Production

The vast amount of waste produced in tackling the COVID-19 pandemic poses a threat to human and environmental health, warns …

News

RDIF, AstraZeneca and others invest in treatments for resistant arterial hypertension

February 1, 2022
Medical Communications

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca, and Unicorn Capital Partners, a biotech-specialised VC fund, announced …

News

FDA approves Vabysmo to treat vision-threatening retinal conditions

January 31, 2022
Sales and Marketing

The FDA has approved vabysmo (faricimab-svoa) for the treatment of neovascular or “wet” age-related macular degeneration and diabetic macular edema. …

News

Almirall announces licensing agreement to accelerate antibody drug discovery

January 31, 2022
Sales and Marketing

Almirall has announced a multi-target licensing agreement with Ablexis, focussed on licensing its AlivaMab Mouse technology, and a research collaboration …

News

Positive CHMP opinion for treatment of rare unpredictable disease

January 31, 2022
Sales and Marketing

Blueprint Medicines has announced that the CHMP has adopted a positive opinion recommending to expand the current indication for AYVAKYT® …

News

CHMP recommends approval of dupixent for children with severe asthma

January 31, 2022
Sales and Marketing

The EMA’s CHMP has adopted a positive opinion recommending the extension of the approval of Dupixent (dupilumab) for children with …

News

Supplemental NDA accepted for leukaemia treatment in China

January 28, 2022
Medical Communications

BeiGene, focused on developing innovative and affordable medicines, announced that the Center for Drug Evaluation (CDE) of the China National …

News

India: DCGI approval for trialling of nasal COVID-19 vaccine

January 28, 2022
Medical Communications

The Drugs Controller General of India (DCGI) has given permission to Bharat Biotech to conduct clinical trials for the use …

News

Launch of pioneering platform to accelerate mental health treatment discovery

January 28, 2022

The clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, atai Life Sciences, has launched a platform …

News

The downfall of COVID-19 lies in new generation anti-viral drugs, says WHO

January 28, 2022
Medical Communications

In a BBC News interview, WHO shared their views against easing pandemic restrictions, as new variants flare up anywhere until …

News

Oncology history: Immunocore claims first-ever FDA approval of melanoma drug

January 27, 2022
Business Services

Immunocore has claimed a piece of history in biotech industry, becoming the first company to secure an FDA approval for …

News

Gilead combo therapy hit with FDA hold over serious adverse events

January 27, 2022
Business Services

The FDA has placed a partial clinical hold on studies conducted by Gilead Sciences assessing the combination of magrolimab plus …

News
isaac-quesada-sij6sanetye-unsplash

Face mask rules and COVID-19 passes end in England, care home restrictions ease

January 27, 2022
Business Services

The government has announced that there will be no limit on the number of visitors to care homes in England. …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026